Recognition and Management of Metabolic Epilepsies - Summary - MDSpire
Advertisement
Commentary & Perspectives
Recognition and Management of Metabolic Epilepsies
This video presents a clinically grounded overview of recent advances in neurogenetics and precision-based therapies for severe childhood-onset neurological disorders, including Dravet syndrome and related epileptic encephalopathies
Dr. Luca Farrugia, a child neurology resident, explores recent advances in neurogenetics and precise therapies for severe childhood-onset neurological disorders such as Dravet syndrome. The discussion emphasizes the genetic and cellular pathophysiology of these conditions, revealing how single-gene mutations affect neuronal signaling and contribute to complex seizure phenotypes. It critiques traditional antiseizure therapies, advocating for disease-modifying strategies. Emerging therapies, including gene replacement and modulation, are examined for their safety, delivery challenges, and clinical trial outcomes, underlining the importance of clinical research in pediatrics.
